Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathiesJOURNAL OF NEUROINFLAMMATIONIF10.12024-03-271OAAI
Analog of kynurenic acid decreases tau pathology by modulating astrogliosis in rat model for tauopathyBIOMEDICINE & PHARMACOTHERAPYIF7.52022-08-019OAAI
Tau Protein and Its Role in Blood-Brain Barrier DysfunctionTau蛋白及其在血脑屏障功能障碍中的作用FRONTIERS IN MOLECULAR NEUROSCIENCEIF3.82020-09-30112OAAI
Changes of Cerebrospinal Fluid Peptides due to TauopathyJOURNAL OF ALZHEIMERS DISEASEIF3.12017-04-2710PREAI
Quantitative analysis of phenylalanine, tyrosine, tryptophan and kynurenine in rat model for tauopathies by ultra-high performance liquid chromatography with fluorescence and mass spectrometry detectionJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSISIF3.12016-01-0128PREAI